{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:55:05Z","timestamp":1791201305884,"version":"4.2.0"},"reference-count":41,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Acute myocardial infarction-related cardiogenic shock (AMI-CS) remains associated with high mortality despite advances in revascularization, critical care, and temporary mechanical circulatory support (MCS). Recent randomized trials have challenged the concept of routine device-based therapy and highlighted the importance of matching MCS strategy to shock phenotype, timing, and patient risk profile. Methods: We reviewed contemporary randomized clinical trials and prespecified or post hoc analyses evaluating temporary MCS strategies in adult patients with AMI-CS. PubMed was searched for English-language studies published from January 2021 through June 2026, focusing on intra-aortic balloon pump (IABP), microaxial flow pumps, and venoarterial extracorporeal membrane oxygenation (VA-ECMO\/ECLS). Outcomes of interest included mortality, hemodynamic recovery, end-organ outcomes, and device-related complications. Results: Recent randomized evidence demonstrates that no temporary MCS device provides universal benefit across the heterogeneous AMI-CS population. Routine IABP use has not been associated with improved survival and is now reserved for selected patients requiring modest circulatory support, bridge-to-decision strategies, or specific mechanical complications. The DanGer Shock trial provided the strongest contemporary randomized evidence supporting temporary MCS, demonstrating reduced 180-day mortality with routine Impella CP support in carefully selected patients with STEMI-related cardiogenic shock. However, this benefit was accompanied by increased major bleeding, limb ischemia, acute kidney injury, and renal replacement therapy. Prespecified secondary and exploratory post hoc analyses have generated hypotheses that treatment response may vary according to age, baseline hemodynamics, timing of support, and shock phenotype; however, these findings require prospective validation and should not be interpreted as established treatment-selection criteria. In contrast, ECLS-SHOCK, ECMO-CS, EURO SHOCK, and randomized meta-analytic data did not demonstrate a survival benefit for routine early VA-ECMO in broad AMI-CS populations and consistently identified higher rates of bleeding and vascular complications. Strategies for routine early left ventricular unloading during VA-ECMO have improved physiologic parameters but have not demonstrated a mortality benefit. Conclusions: Contemporary randomized trials have shifted the role of temporary MCS in AMI-CS from routine device deployment toward individualized, phenotype-guided therapy. Impella CP, as evaluated in the DanGer Shock trial, currently provides the strongest randomized survival signal but should be applied selectively in patients with predominantly left ventricular failure treated within experienced shock systems. VA-ECMO remains an important rescue option in carefully selected patients with refractory circulatory collapse, severe hypoxemia, cardiac arrest, or biventricular failure, although routine early use is not supported. Future research should focus on earlier shock phenotyping, physiology-guided device selection, complication reduction, and strategies that integrate mechanical support with recovery-focused care.<\/jats:p>","DOI":"10.3390\/jcm15197664","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:57:46Z","timestamp":1791197866000},"page":"7664","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock: Lessons from Contemporary Randomized Trials"],"prefix":"10.3390","volume":"15","author":[{"given":"Osama","family":"Odeh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Houston Methodist The Woodlands Hospital, Conroe, TX 77385, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6882-8715","authenticated-orcid":false,"given":"Mariam","family":"Al-Bayati","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8520-5783","authenticated-orcid":false,"given":"Ali","family":"Abdulrazzaq","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Brookdale Hospital Medical Center, Brooklyn, NY 11212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala W.","family":"Abdallah","sequence":"additional","affiliation":[{"name":"Division of Cardiology, LSU Health Sciences Center, Louisiana State University Health Sciences Center, Shreveport, LA 70802, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanval","family":"Shah","sequence":"additional","affiliation":[{"name":"Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist The Woodlands Hospital, Conroe, TX 77385, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0140-6736(24)01818-X","article-title":"Cardiogenic shock","volume":"404","author":"Adamo","year":"2024","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit","volume":"74","author":"Jentzer","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","first-page":"E213","article-title":"Application of the SCAI classification in a cohort of patients with cardiogenic shock","volume":"96","author":"Schrage","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.jacc.2025.04.025","article-title":"Mechanical Circulatory Support in Acute Myocardial Infarction-Cardiogenic Shock: 2025 Acute Coronary Syndrome Guideline in Context","volume":"85","author":"Murugiah","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/eurheartj\/ehaf924","article-title":"Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: The OPTION-STEMI trial","volume":"47","author":"Kim","year":"2026","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.jcin.2025.07.035","article-title":"Percutaneous Coronary Intervention in Multivessel Disease and Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy","volume":"18","author":"Marquard","year":"2025","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2020.11.025","article-title":"Predictive Value of the Residual SYNTAX Score in Patients with Cardiogenic Shock","volume":"77","author":"Rouanet","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107363","DOI":"10.1016\/j.ahj.2026.107363","article-title":"Primary percutaneous coronary intervention within the first hour: Insights from early-treated patients with ST-elevation myocardial infarction","volume":"295","author":"Armstrong","year":"2026","journal-title":"Am. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/heartjnl-2024-324883","article-title":"Mechanical circulatory support for patients with infarct-related cardiogenic shock: A state-of-the-art review","volume":"111","author":"Moller","year":"2025","journal-title":"Heart"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0140-6736(23)01607-0","article-title":"Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: An individual patient data meta-analysis of randomised trials","volume":"402","author":"Zeymer","year":"2023","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.123.066179","article-title":"Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial","volume":"148","author":"Kim","year":"2023","journal-title":"Circulation"},{"key":"ref_15","first-page":"203","article-title":"Early left ventricular unloading after venoarterial extracorporeal membrane oxygenation: 1-year outcomes of the EARLY-UNLOAD randomized clinical trial","volume":"14","author":"Lim","year":"2025","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/ejhf.3014","article-title":"Early left atrial venting versus conventional treatment for left ventricular decompression during venoarterial extracorporeal membrane oxygenation support: The EVOLVE-ECMO randomized clinical trial","volume":"25","author":"Park","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0140-6736(20)31047-3","article-title":"Temporary circulatory support for cardiogenic shock","volume":"396","author":"Combes","year":"2020","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamacardio.2024.4197","article-title":"Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical Trial","volume":"10","author":"Udesen","year":"2025","journal-title":"JAMA Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock","volume":"390","author":"Jensen","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/CIRCULATIONAHA.124.072370","article-title":"Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial","volume":"150","author":"Zweck","year":"2024","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","article-title":"Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial","volume":"147","author":"Ostadal","year":"2023","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4244\/EIJ-D-23-00204","article-title":"Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: The multicentre, randomised EURO SHOCK trial","volume":"19","author":"Banning","year":"2023","journal-title":"EuroIntervention"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jchf.2020.09.005","article-title":"A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock","volume":"8","author":"Tehrani","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal Life Support in Infarct-Related Cardiogenic Shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCULATIONAHA.118.038201","article-title":"Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial","volume":"139","author":"Thiele","year":"2019","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcin.2025.10.051","article-title":"Bleeding in Patients With Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy","volume":"19","author":"Vandenbriele","year":"2026","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_27","first-page":"466","article-title":"Escalation of mechanical circulatory support in patients with STEMI-related cardiogenic shock: A post hoc analysis of the DanGer Shock trial","volume":"15","author":"Schrage","year":"2026","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jacc.2024.11.003","article-title":"Treating Older Patients in Cardiogenic Shock With a Microaxial Flow Pump: Is it DANGERous?","volume":"85","author":"Klein","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jamacardio.2025.3337","article-title":"Systolic Blood Pressure and Microaxial Flow Pump\u2013Associated Survival in Infarct-Related Cardiogenic Shock","volume":"10","author":"Mikkelsen","year":"2025","journal-title":"JAMA Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e015718","DOI":"10.1161\/CIRCINTERVENTIONS.125.015718","article-title":"Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock Trial","volume":"19","author":"Jensen","year":"2026","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacc.2025.09.019","article-title":"Sex-Specific Microaxial Flow Pump Use and Outcomes in Infarct-Related Cardiogenic Shock in the DanGer Shock Trial","volume":"87","author":"Mangner","year":"2026","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/eurheartj\/ehae610","article-title":"Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial","volume":"45","author":"Desch","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ejhf.3398","article-title":"Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: 1-year outcomes of the multicentre, randomized ECMO-CS trial","volume":"27","author":"Ostadal","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2607","DOI":"10.1097\/CCM.0000000000006893","article-title":"Extracorporeal Membrane Oxygenation Complications Are Not Causal for Mortality in Patients with Infarct-Related Cardiogenic Shock: A Mediation Analysis of the Extracorporeal Life Support in Infarct-Related Cardiogenic Shock (ECLS-SHOCK) Trial","volume":"53","author":"Thevathasan","year":"2025","journal-title":"Crit. Care Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jcin.2024.12.010","article-title":"Different Mechanical Circulatory Support Strategies for Infarct-Related Cardiogenic Shock: A Subanalysis of the ECLS-SHOCK Trial","volume":"18","author":"Feistritzer","year":"2025","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1002\/ehf2.15446","article-title":"Prognostic impact of SCAI shock severity classes in AMI-related cardiogenic shock: A sub-study of the ECLS-SHOCK Trial","volume":"12","author":"Jentzer","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13054-025-05513-5","article-title":"Cardiac index, SvO2 or pCO2 gap may determine benefit from ECMO in cardiogenic shock: Post-hoc analysis of the multicenter, randomized ECMO-CS trial","volume":"29","author":"Ostadal","year":"2025","journal-title":"Crit. Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.120.048792","article-title":"Left Ventricular Unloading Is Associated with Lower Mortality in Patients with Cardiogenic Shock Treated with Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study","volume":"142","author":"Schrage","year":"2020","journal-title":"Circulation"},{"key":"ref_39","first-page":"1009","article-title":"Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: Percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"10","author":"Karami","year":"2021","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.acvd.2019.10.005","article-title":"Mechanical circulatory support with the Impella\u00ae LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study","volume":"113","author":"Bochaton","year":"2020","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7664\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:10:15Z","timestamp":1791198615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":41,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197664"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197664","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]}}}